US FDA Nod for Indian Drug Maker Jubilant's Anti-Infection Drug Levofloxacin
The company, which had 806 filings for formulations till March 31, 2015, got approval for 368 of them from various regions worldwide, including 72 from FDA.
The company, which had 806 filings for formulations till March 31, 2015, got approval for 368 of them from various regions worldwide, including 72 from FDA.
As of June 30, 2015, Jubilant Life Sciences had a total of 815 filings for formulations, of which 389 have been approved in various regions globally. This includes 72 ANDAs filed in the US, of which 38 have been approved and 46 Dossier filings in Europe.
Source-PTI
Drug Firm Jubilant Life Sciences Gets ANDA Approval for Generics Mycophenolate Mofetil and Rizatriptan
The Indian drug company, Jubilant Life Sciences, has announced in a statement that it has received final approvals for its generics Mycophenolate Mofetil and Rizatriptan from the FDA.
The Indian drug company, Jubilant Life Sciences, has announced in a statement that it has received final approvals for its generics Mycophenolate Mofetil and Rizatriptan from the FDA.
New Medications That Would Prevent Migraine Headaches on the Anvil
Pharmaceutical companies are testing new drugs that could bring relief for a substantial number of migraine sufferers with minimal side effects.
Pharmaceutical companies are testing new drugs that could bring relief for a substantial number of migraine sufferers with minimal side effects.
Women are Likelier to Suffer Three Times More from Migraines Than Men
Exposure to parental domestic violence or emotional abuse during childhood increases risk of migraine and it effects three times as more women than men.
Exposure to parental domestic violence or emotional abuse during childhood increases risk of migraine and it effects three times as more women than men.
